Science Explorer Back to mapMap

Most cited papers from Testicular Cancer Commons

What are the most cited papers from Testicular Cancer Commons?

The most cited paper from Testicular Cancer Commons is "Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum" (Lucia Nappi et al., 2019), with 127 citations. Next come "Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors" (67) and "Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers" (38).

Showing 31 of 31 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum Lucia Nappi et al. · Journal of Clinical Oncology Open access 25 Sep 2019 127
2 Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors Lucia Nappi, Marisa Thi, Nabil Adra et al. · European Urology Open access 4 Nov 2020 67
3 Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers Lucia Nappi et al. · The Oncologist Open access 31 Jul 2020 38
4 MicroRNAs as Biomarkers for Germ Cell Tumors Lucia Nappi, Craig R. Nichols · Urologic Clinics of North America 29 May 2019 25
5 The Connection Between Testicular Cancer, Minority Males, and Planned Parenthood Wesley B. Adams, Michael J. Rovito, Mike Craycraft · American Journal of Men s Health Open access 16 Jul 2018 10
6 The role of micro-RNAs in management of germ cell tumors: future directions Lucia Nappi, Christian Kollmannsberger, Craig R. Nichols · Current Opinion in Urology 19 Jan 2020 9
7 TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors Jack V. W. Bacon, Patrizia Giannatempo, Giovanna Cataldo et al. · The Oncologist Open access 27 Sep 2022 8
8 Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe Christian Kollmannsberger, Lucia Nappi, Craig R. Nichols · Journal of Clinical Oncology 10 Jun 2019 8
9 A Call to Action to Review the USPSTF’s Recommendation for Testicular Self-Examination Michael J. Rovito, Keri Allen, Ajay K. Nangia et al. · American Journal of Men s Health Open access Sep 2022 7
10 Genomic features of mediastinal germ cell tumors: a narrative review Güliz Özgün, Craig R. Nichols, Christian Kollmannsberger et al. · Mediastinum ReviewOpen access 19 Jul 2022 7
11 Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer Xiaosong Meng, Murtaza Ahmed, Kevin Dale Courtney et al. · Frontiers in Oncology Open access 7 Oct 2021 7
12 Testicular Cancer Incidence and Mortality Within Rural and Urban Regions Michael J. Rovito, Skyler Taylor, Ryan Lockwood et al. · Journal of Adolescent and Young Adult Oncology Apr 2020 6
13 Humor-Based Messaging in Testicular Cancer Awareness Campaigns: A Comparative Critical Review Michael J. Rovito, Keri Allen, Andres G. Perez et al. · American Journal of Men s Health Open access Nov 2023 4
14 Novel treatment options for refractory Germ Cell Tumours: back to the bench! Christian Kollmannsberger, Lucia Nappi, Craig R. Nichols · Annals of Oncology Open access 16 Nov 2017 4
15 Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer Güliz Özgün, Neda Abdalvand, Gizem Özcan et al. · JCO Clinical Cancer Informatics Open access Aug 2025 3
16 Narrative review of developing new biomarkers for decision making in advanced testis cancer Lucia Nappi, Craig R. Nichols, Christian Kollmannsberger · Translational Andrology and Urology ReviewOpen access 16 Jun 2021 3
17 Back to the Future—Moving Forward for Testicular Cancer Survivors Craig R. Nichols, Lucia Nappi, Christian Kollmannsberger et al. · JNCI Cancer Spectrum Open access 2 Oct 2019 3
18 Ten thousand attentive hours, rapid learning, dissemination of knowledge and the future of experience-based care in germ-cell tumors Craig R. Nichols, Torgrim Tandstad, William Thomas Lowrance et al. · Annals of Oncology Open access 9 Dec 2017 3
19 Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumors Arkhjamil Angeles, Nastaran Khazamipour, Gurdial Dhillon et al. · PLoS ONE Open access 9 May 2025 2
20 Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option? Lawrence H. Einhorn, Nabil Adra, Nasser H. Hanna et al. · Journal of Clinical Oncology 7 Jul 2020 2
21 Current Practice Patterns Surrounding Fertility Concerns in Stage I Seminoma Patients: Survey of United States Radiation Oncologists Carl M. Post, Aditya Jain, Catherine Degnin et al. · Journal of Adolescent and Young Adult Oncology 16 Jan 2018 2
22 First interim analysis of SWOG S1823: Operating characteristics of circulating microRNA 371a-3p (miR371) in predicting active germ cell malignancy (aGCM) in patients (pts) with early-stage testicular cancer. Lucia Nappi et al. · Journal of Clinical Oncology 3 Jun 2026 1
23 Novel High-Dose Chemotherapy Regimens in Relapsed/Refractory Germ Cell Cancer: Have We Made Progress? Christian Kollmannsberger, Lucia Nappi, Craig R. Nichols · Clinical Cancer Research 13 Nov 2025 1
24 A Cross-Sectional Analysis of Testicular Cancer Symptom Recognition and Stage of Diagnosis Michael J. Rovito, Mike Craycraft, Wesley B. Adams et al. · American Journal of Men s Health Open access May 2022 1
25 On thin ice: barriers to adoption of surveillance for patients with stage I testicular seminoma. Survey of US radiation oncologists Aditya Jain, Catherine Degnin, Yiyi Chen et al. · International braz j urol Open access Jun 2018 1
26 Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial Brian Robin Hu et al. · The Journal of Urology 9 Apr 2025 0
27 Favorable long-term Health Related Quality of Life in cured survivors of testicular cancer management. So, what now? Anjaline D'Souza, Jennifer M. King, Lucia Nappi et al. · Annals of Oncology Open access Dec 2023 0
28 Relato de caso: Tumor testicular bilateral metacrônico Rafael Scandiuzzi, Rayane Morais Costa, Leticia Alves de Melo · Brazilian Journal of Health Review Open access 27 Sep 2022 0
29 So, now what?: Reflections on socioeconomic factors, testicular cancer, and health care accessibility Michael J. Rovito, Mike Craycraft, Walker Talton et al. · Cancer Open access 17 Feb 2021 0
30 Plasma miR-371a-3p for detection of non-teratomatous viable germ cell tumor in testicular cancer Lucia Nappi, Marisa Thi, Bernhard J. Eigl et al. · Annals of Oncology Open access Oct 2018 0
31 Management of Disseminated Germ Cell Tumor in Adults Craig R. Nichols, Christopher R. Porter, Christian Kollmannsberger · Pediatric oncology Book chapter 3 Aug 2013 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.